Clover Health Investments, Corp vs Johnson & Johnson — Stock Comparison

CLOV
Clover Health Investments, Corp
$2.71
▼ 1.45%
vs
JNJ
Johnson & Johnson
$227.19
▼ 1.16%
Q·Score Winner
Johnson & Johnson
JNJ7.1/10vs 5.3/10

Q·Score Breakdown

5.3
Bearish
Overall
7.1
Bullish
1.5
Quality
9.3
8
Health
6.5
7.3
Growth
5.1
6.3
Valuation
7.3
4.1
Sentiment
6.5
CLOV

Clean balance sheet with low leverage (0.0× debt-to-equity).

currently unprofitable (-4% margin).

JNJ

High-quality business with 26% return on equity and 22% profit margins.

earnings contracting 53% year-over-year.

Analyst Consensus

HOLD
Target $2.82 (+3.9%)
3 analysts
BUY
Target $252.42 (+11.1%)
24 analysts

Fundamentals

CLOV
JNJ
Trailing P/E
26.3×
30.1×
Forward P/E
17.9×
-4.4%
Profit Margin
21.8%
18.5%
Gross Margin
68.0%
-26.3%
ROE
26.4%
44.7%
Revenue Growth
9.9%
Earnings Growth
-52.9%
2.25
Beta
0.33
Price / Book
$1.4B
Market Cap
$546.9B
$2 – $4
52-Week Range
$146 – $252

Q·Score is an educational tool and is not financial advice. Data provided by Yahoo Finance. Updated on each page load. How it's calculated →